GlassScriptPhysician profile
Joseph Taub
NPI 1801851449
$833.59
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $111 · 2021: $120 · 2022: $117 · 2023: $37.77 · 2024: $17.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $55.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $55.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $196.03 | 2019-2023 | Regranex, Collagenase Santyl |
| Melinta Therapeutics, LLC | $125.00 | 2019 | |
| Horizon Therapeutics Plc | $119.79 | 2021 | |
| Integra Lifesciences Corporation | $109.76 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $98.22 | 2022 | |
| Cardiovascular Systems INC. | $97.32 | 2020 | |
| Paratek Pharmaceuticals, INC. | $36.51 | 2022-2024 | Nuzyra |
| Kerecis Limited | $22.62 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Merck Sharp & Dohme LLC | $15.03 | 2019 | |
| Orthofix Medical, INC. | $13.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Taub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.